These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36929289)

  • 1. Enhancing Oral Performance of Paclitaxel Lipid-Mimic Prodrug via Modulating Type of Fatty Acids.
    Miao YF; Ye Q; Zhang MY; Gao L; Wang XY; Zhong WX; Wang ZX; He ZG; Tian CT; Sun J
    Adv Healthc Mater; 2023 Jul; 12(19):e2203118. PubMed ID: 36929289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Intestinal Digestion and On Site Tumor-Bioactivation are the Two Important Determinants for Chylomicron-Mediated Lymph-Targeting Triglyceride-Mimetic Docetaxel Oral Prodrugs.
    Tian C; Guo J; Wang G; Sun B; Na K; Zhang X; Xu Z; Cheng M; He Z; Sun J
    Adv Sci (Weinh); 2019 Dec; 6(24):1901810. PubMed ID: 31871861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid.
    Han S; Quach T; Hu L; Lim SF; Zheng D; Leong NJ; Sharma G; Bonner D; Simpson JS; Trevaskis NL; Porter CJH
    Mol Pharm; 2023 May; 20(5):2675-2685. PubMed ID: 36996486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating a Lipophilic Disulfide-Bridged Linoleic Prodrug into a Self-Microemulsifying Drug Delivery System to Facilitate Oral Absorption of Paclitaxel.
    Zhang M; Guo C; Miao Y; He Z; Tian C; Sun J
    Mol Pharm; 2023 Jan; 20(1):461-472. PubMed ID: 36525349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
    Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
    J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The length of disulfide bond-containing linkages impacts the oral absorption and antitumor activity of paclitaxel prodrug-loaded nanoemulsions.
    Gao Y; Zuo S; Li L; Liu T; Dong F; Wang X; Zhang X; He Z; Zhai Y; Sun B; Sun J
    Nanoscale; 2021 Jun; 13(23):10536-10543. PubMed ID: 34100041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long chain triglyceride-lipid formulation promotes the oral absorption of the lipidic prodrugs through coincident intestinal behaviors.
    Tian CT; Guo JJ; Miao YF; Wang HL; Ye Q; Guo CL; Zhang MY; He ZG; Sun J
    Eur J Pharm Biopharm; 2022 Jul; 176():122-132. PubMed ID: 35643367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism.
    Wang X; Zhang C; Han N; Luo J; Zhang S; Wang C; Jia Z; Du S
    Drug Deliv; 2021 Dec; 28(1):1664-1672. PubMed ID: 34338567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidic prodrug approach for improved oral drug delivery and therapy.
    Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
    Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipophilic Prodrugs of SN38: Synthesis and in Vitro Characterization toward Oral Chemotherapy.
    Bala V; Rao S; Li P; Wang S; Prestidge CA
    Mol Pharm; 2016 Jan; 13(1):287-94. PubMed ID: 26623947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Conjugation Position and Linker Chemistry on the Lymphatic Transport of a Series of Glyceride and Phospholipid Mimetic Prodrugs.
    Han S; Quach T; Hu L; Lim SF; Gracia G; Trevaskis NL; Simpson JS; Porter CJH
    J Pharm Sci; 2021 Jan; 110(1):489-499. PubMed ID: 33069711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive Triglyceride Turnover into the Mesenteric Lymph Is Unable to Support Efficient Lymphatic Transport of a Biomimetic Triglyceride Prodrug.
    Han S; Hu L; Quach T; Simpson JS; Trevaskis NL; Porter CJH
    J Pharm Sci; 2016 Feb; 105(2):786-796. PubMed ID: 26540595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs.
    Mao Y; Zhang Y; Luo Z; Zhan R; Xu H; Chen W; Huang H
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the fluorination effect on the self-assembly characteristics,
    Wang X; Yang B; Li L; Liu T; Zuo S; Chi D; He Z; Sun B; Sun J
    Theranostics; 2021; 11(16):7896-7910. PubMed ID: 34335971
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphatic Transport and Lymphocyte Targeting of a Triglyceride Mimetic Prodrug Is Enhanced in a Large Animal Model: Studies in Greyhound Dogs.
    Han S; Hu L; Gracia ; Quach T; Simpson JS; Edwards GA; Trevaskis NL; Porter CJ
    Mol Pharm; 2016 Oct; 13(10):3351-3361. PubMed ID: 27608166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
    Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.